GFM
DGX icon

GF Fund Management’s Quest Diagnostics DGX Stock Holding History

GF Fund Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$646K Buy
3,048
+32
+1% +$6.28K 0.01% 203
2026
Q1 		$591K Hold
3,016
– – 0.01% 211
2025
Q4 		$523K Sell
3,016
-55
-2% -$10K 0.01% 224
2025
Q3 		$585K Buy
3,071
+298
+11% +$52.9K 0.01% 217
2025
Q2 		$498K Sell
2,773
-20
-0.7% -$3.47K 0.01% 254
2025
Q1 		$473K Hold
2,793
– – 0.01% 259
2024
Q4 		$421K Buy
+2,793
New +$434K 0.01% 239

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

GF Fund Management's DGX Position: Q2 2026 in Review

GF Fund Management increased its Quest Diagnostics (DGX) stake by 1.1% in Q2 2026, buying an estimated $6.28K and bringing the position to 3,048 shares worth $646K. The position accounts for 0.01% of the portfolio, ranked #203.

GF Fund Management first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • GF Fund Management held 3,048 shares of Quest Diagnostics worth $646K as of Q2 2026.
  • GF Fund Management bought 32 Quest Diagnostics shares in Q2 2026, an estimated $6.28K.
  • Quest Diagnostics made up 0.01% of GF Fund Management's portfolio in Q2 2026, its #203 holding.
  • GF Fund Management first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.